See you in 2023
September 21 & 22
Woodstock VT
Email: 3Dsymposium@hitchcock.org
Dartmouth College Green by Peter Rintels
For 20 years the 3D Dartmouth Device Symposium has been bringing together a distinguished group of thought leaders representing the clinical, business, governmental, financial and legal segments of the medical device community.
The Symposium provides an important forum to exchange ideas and discuss problems common to us all as we strive to bring new technologies to improve patient care.
PROGRAM
3D 2022
October 20 & 21, 2022
Woodstock VT
Session I
Real World Evidence
Aggregating large representative data sets-Leveraging AI
​
Moderator
Michael Jaff, DO / Boston Scientific
Round Table Conversation
Ryan Ahern, MD / Truveta​
David Cohen, MD / CRF
Harlan Krumholz, MD / Yale/Hugo
Steve Farmer, MD, PhD / CMS
​
Truveta: Paradigm Shift-Impact on Post Market Assessment
Ryan Ahern, MD, Chief Medical Officer / Truveta
​
Meet Hugo
Harlan Krumholz, MD / Hugo Health & Yale University
​
Session II
Real World Evidence: Established Mandated Registries (NCDR, TVT)
Why is it so difficult to embed RCTs?
​
Moderator
Michael Mack / Baylor Scott & White Health
​
SAFE-PCI Women
Mitch Krucoff, DCRI-Duke
​
TAVR-RV/LV (PRAGMATIC-PACE)
Michael Mack / Baylor Scott & White Health
Round Table Conversation
Ori Ben-Yehuda, MD / CRF
Nicole Ibrahim / FDA-CDRH
Martin Leon, MD / Columbia/CRF
Sreek Vemulapalli, MD / NCDR & Duke University​
Larry Wood / Edwards Life Sciences
​
Session III
TCET (Previously known as MCIT)
Where do we go from here?
What does it mean for devices with the Breakthrough designation?
​
Moderator
Emily Zeitler, MD, MPH / Heart & Vascular Center, Dartmouth Health
​
Framing Comments
Steven Farmer, MD, PhD
Chief Strategy Officer for Coverage
Centers for Medicare and Medicaid Services
Round Table Conversation
Andrew Farb / FDA-CDRH
Keith Dawkins, MD / Shockwave Medical
Tamara Syrek-Jensen, JD / CMS
Sean Tunis, MD / Tufts Medical Center
​
Session IV
On the Cusps: Tricuspid Valve Devices
CED/NCD Is it appropriate/How should it be constructed?
​
Moderator & Framing Comments
Martin B. Leon, MD / Columbia University / CRF
Round Table Conversation
James Fann, MD / Half Moon Medical/Stanford
Steven Farmer, MD, PhD / CMS
Ted Feldman, MD / Edwards Lifesciences
Neal Moat, MS, FRCS / Abbott
Mauro Moscucci, MD / FDA-CDRH
Michael Young, MD / Dartmouth Health/Heart &
Vascular Center
CEO Round Table Conversation: Emerging from COVID - Has the Dust Really Settled-Have we reached a new Equilibrium
​
Moderator
Paul LaViolette
Managing Partner, SV Health Investors
​
Andrew Cleeland / Fogarty Innovation
Doron Harlev / Affera/Medtronic
Mike Mussallem / Edwards Life Sciences
Session V
Medical Device-Smart App Driven Management:
Navigating new Landscapes
Leveraging AI & Machine Learning, addressing cybersecurity concerns.
A Fictitious Case Study
​
Moderator
Robert Kazmierski, PhD
FDA-CDRH
​
Framing the Problem
Adam Jacobs / Sunrise Labs
​
VaporWare Medical (A Fictitious Case)
Aaron V. Kaplan
Heart & Vascular Center/Dartmouth Health
Case Study Participants
Lauren Baker, PhD / Insight Medical Consulting
Adam Jacobs / Sunrise Labs
Brendan O'Leary / FDA-CDRH
Jessica Paulsen / FDA-CDRH
Sam Surette / Apple
​
​
Session VI
Moving Primary Care from the Clinic to the Pharmacy/Retail Store
Impact on the Medical Device Ecosystem
​
Moderator
Lauren Gilstrap, MD
Heart & Vascular Center/Dartmouth Health
A Vison for the Future
Srinath Adusumalli, MD
CVSHealth
​
Round Table Conversation
Don Cutlip, MD / Beth Israel-Deaconess/Harvard
Jodi Akin / Hawthorne Effect
Ami Bhatt / American College of Cardiology
Ian Meredith, MD, PhD / Boston Scientific
Brendan O'Leary / FDA-CDRH
​
PANEL MEMBERS
Alphabetical - Last Name
Attendees
Alphabetical - Last Name
